yea i suppose so, but then something in his world changed. And he thought maybe we can change this for the better. I would be interested to see what it was. Maybe he can just make more money doing this.
If the development costs really are lower, and the targeted drugs have enough of a market, it seems totally reasonable to reduce end user costs and still make a bunch of money.
Pharmacies are not allowed to fill will biologic generics without FDA bio-interchangeable approval, which no biologic in the US has obtained. They would not be able to substitute an alternative drug either.